Search results (43)
« Back to News & OpinionNews and Opinion from the Pandemic Sciences Institute at the University of Oxford
Prioritising research to better address high-consequence outbreaks
19 March 2025
A new paper published in BMC Medicine analyses research prioritisation approaches for high-consequence pathogens.
New paper outlines ethical issues in clinical metagenomics
7 March 2025
This week, University of Oxford researchers published the first paper mapping clinical ethics questions raised by new metagenomic techniques for diagnosing disease in clinical practice.
Advances in AI can help prepare the world for the next pandemic
19 February 2025
- Epidemiology & data
- Ethics, social science & humanities
- Pathogen biology & new threats
- Research news
- Vaccines, treatments, diagnostics & trials
In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.
Study provides new insights into mpox clinical outcomes and transmission
16 January 2025
Results of MOSAIC, a European observational study led by researchers at PSI and ISARIC, provides evidence on how the clade IIb mpox virus affects patients and the risks of onward transmission.
Pig research paves way for human respiratory vaccine development
9 January 2025
A study in pigs, which shows that inhaled vaccines could potentially reduce viral transmission and improve efficiency, is an important step toward advancing vaccines for human use.
Optimising testing for disease surveillance with machine learning
19 December 2024
A new machine learning-informed strategy could support public health leaders to design better disease surveillance during a disease outbreak.
Nipah Virus Research Day showcases cross-disciplinary advances
6 December 2024
Over 100 researchers convened for a PSI-hosted event exploring the latest interdisciplinary research to combat this deadly virus.
University of Oxford unveils new vaccine development partnership
15 November 2024
Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.
New study traces impact of COVID-19 pandemic on global movement and evolution of seasonal flu
11 November 2024
Increased genomic surveillance capacity allowed a deeper insight into the global distribution patterns of seasonal flu and other respiratory viruses.
Reconstructing a lifetime of flu infections to understand long-term trends
8 November 2024
Using antibody data and mathematical modelling, a new study estimates annual patterns of influenza infection and protection over the past fifty years.
Large-scale study on Long Covid highlights urgent, global need for investment
22 October 2024
A new study in BMJ Global Health reveals the key Long Covid characteristics affecting populations worldwide, including fatigue, shortness of breath and having trouble thinking clearly. 6-12 months after hospital discharge, 70% of study participants were affected by Long Covid in high-income countries, and 42% in low and middle-income countries.
Study suggests possible new transmission route for highly pathogenic avian influenza
17 October 2024
Understanding actual “bird flu” rates in humans will help prevent further spillover and a potential new pandemic.
Study explores aerosol immunisation as path to broadly protective influenza vaccine
16 October 2024
Scientists at PSI and Pirbright have taken a significant step towards developing a universal influenza vaccine.
Professor Sassy Molyneux awarded NIHR Global Health Research Professorship
5 September 2024
PSI Investigator Professor Sassy Molyneux has received a prestigious five-year NIHR Global Health Research Professorship. This award, granted to only five distinguished scientists annually, will support Professor Molyneux’s research on protecting frontline staff from moral distress.
COVID-19 phone app shown to provide real-time information on the spread of infectious diseases
12 July 2024
Researchers analysing data from mobile phone apps used during the COVID-19 pandemic found that digital contact tracing can help public health bodies to better monitor and analyse evolving epidemics.
Pandemic computer simulations to guide future vaccine trials
23 May 2024
PSI scientists are launching a new computer simulations project to model vaccine clinical trial designs and strengthen global response to pandemic threats.
New ethical framework for coercive antimicrobial stewardship policies
29 April 2024
Published in the journal Public Health Ethics, the research introduces an ethical framework for assessing the use of coercive antimicrobial stewardship policies to address the ‘silent pandemic’ of antimicrobial resistance.
Researchers enrol record number of patients for landmark plague trial
26 April 2024
A randomised controlled trial to evaluate the efficacy and safety of treatments for bubonic plague has enrolled over 220 patients in Madagascar, marking a critical milestone in evidence generation for plague treatments.
New Pandemic PACT research programme launched
21 March 2024
The Pandemic Sciences Institute, in collaboration with the global coalition of health research funders GloPID-R and UKCDR, has launched a new research programme including an interactive platform to track and analyse over $7 billion in global pandemic research funding.
Study reveals high number of persistent COVID-19 infections in the general population
21 February 2024
A new study – led by researchers at PSI – has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published today in the journal Nature.